Candriam SCA’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-240,000
| Closed | -$6.06M | – | 689 |
|
|
2024
Q1 | $6.06M | Buy |
240,000
+56,000
| +30% | +$1.41M | 0.04% | 309 |
|
|
2023
Q4 | $4.3M | Buy |
184,000
+84,000
| +84% | +$1.96M | 0.03% | 350 |
|
|
2023
Q3 | $5.06M | Sell |
100,000
-15,000
| -13% | -$759K | 0.04% | 311 |
|
|
2023
Q2 | $5.37M | Buy |
115,000
+10,000
| +10% | +$467K | 0.04% | 327 |
|
|
2023
Q1 | $3.7M | Sell |
105,000
-105,000
| -50% | -$3.7M | 0.03% | 433 |
|
|
2022
Q4 | $11.5M | Buy |
+210,000
| New | +$11.5M | 0.08% | 245 |
|
|
2022
Q1 | – | Sell |
-88,876
| Closed | -$1.88M | – | 807 |
|
|
2021
Q4 | $1.88M | Sell |
88,876
-37,791
| -30% | -$799K | 0.01% | 558 |
|
|
2021
Q3 | $2.83M | Hold |
126,667
| – | – | 0.02% | 507 |
|
|
2021
Q2 | $3.14M | Buy |
126,667
+30,269
| +31% | +$751K | 0.02% | 499 |
|
|
2021
Q1 | $2.39M | Hold |
96,398
| – | – | 0.02% | 493 |
|
|
2020
Q4 | $2.49M | Sell |
96,398
-3,102
| -3% | -$80K | 0.02% | 505 |
|
|
2020
Q3 | $3.06M | Sell |
99,500
-58,500
| -37% | -$1.8M | 0.03% | 432 |
|
|
2020
Q2 | $3.94M | Buy |
158,000
+138,000
| +690% | +$3.44M | 0.04% | 379 |
|
|
2020
Q1 | $434K | Hold |
20,000
| – | – | ﹤0.01% | 722 |
|
|
2019
Q4 | $444K | Hold |
20,000
| – | – | ﹤0.01% | 740 |
|
|
2019
Q3 | $455K | Hold |
20,000
| – | – | 0.01% | 691 |
|
|
2019
Q2 | $381K | Buy |
+20,000
| New | +$381K | ﹤0.01% | 765 |
|